With increasing uncertainty for investors amid mixed economic data, Ukraine concerns and potential ECB action, Michael Hewson looks at an interesting divergence in the direction of travel of several key markets.
- Russell 2000 and NASDAQ 100 struggling when compared to the main blue chip US indices, perhaps suggesting risk aversion
- Is the potential merger between AstraZeneca and Pfizer actually beneficial for both parties?
- European indices are being propped up by Draghi’s suggestion that we may see ECB action in June, with EUR/USD finding support at $1.3740
Spread Betting & CFD trading carry a high level of risk to your capital and you can lose more than your initial deposit. Only speculate with money that you can afford to lose. These trading products may not be suitable for all investors so seek independent advice.
Video content by Michael Hewson of CMC Markets.